These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9767764)

  • 21. [Antitubercular agents and their role in the control of tuberculosis].
    Goldman S
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():5-20. PubMed ID: 4445388
    [No Abstract]   [Full Text] [Related]  

  • 22. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
    Rudoĭ NM
    Probl Tuberk; 1974; (10):1-6. PubMed ID: 4213757
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical and bacteriological aspects of the drug resistance of Mycobacterium tuberculosis in patients with chronic destructive pulmonary tuberculosis].
    Korotaev GA; Kozulitsyna TI; Tret'iakova EA; Mamed'iarova FA
    Probl Tuberk; 1986; (7):32-6. PubMed ID: 3094001
    [No Abstract]   [Full Text] [Related]  

  • 24. [Contagion in tuberculosis at the present time: conclusive summary of the Convention].
    Blasi A
    Arch Monaldi; 1972; 27(4):508-16. PubMed ID: 4217604
    [No Abstract]   [Full Text] [Related]  

  • 25. [Changes in tuberculosis].
    Freerksen E
    Internist (Berl); 1978 Mar; 19(3):156-60. PubMed ID: 417040
    [No Abstract]   [Full Text] [Related]  

  • 26. Initial drug resistance pattern in new cases of pulmonary tuberculosis.
    Chandramuki A; Nagarathna S; Veena Kumari HB; Buggi S
    J Assoc Physicians India; 2008 Mar; 56():202. PubMed ID: 18697641
    [No Abstract]   [Full Text] [Related]  

  • 27. [Issues addressed by tuberculosis in France in 2003].
    Bouvet E
    Med Sci (Paris); 2003 Nov; 19(11):1146-51. PubMed ID: 14648486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Microbiological and molecular analysis of mycobacterium tuberculosis complex strains isolated from patients with pulmonary tuberculosis].
    Dworniczak S; Niepsuj G; Konofalski L; Wojtyczka RD; Idzik D; Kepa M; Wydmuch Z; Pacha J; Mazur W; Kieda-Szurkowska J; Nieroda-Müller A; Kozielski J
    Pneumonol Alergol Pol; 2005; 73(1):4-11. PubMed ID: 16539177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of care for elderly pulmonary tuberculosis patients].
    Sasaki Y; Yamagishi F; Yagi T; Hashimoto T; Bekku R; Kawasaki T; Shinozaki A
    Kekkaku; 2007 Oct; 82(10):733-9. PubMed ID: 18018597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for drug resistance in pulmonary tuberculosis inpatients.
    Yang X; Li Y; Wen X; Wu G; Li X
    J Evid Based Med; 2010 Aug; 3(3):162-7. PubMed ID: 21349061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are some people not safer after successful treatment of tuberculosis?
    Yew WW; Leung CC
    Am J Respir Crit Care Med; 2005 Jun; 171(12):1324-5. PubMed ID: 15941841
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current aspects of pulmonary tuberculosis in France].
    Meyer A
    Arch Monaldi; 1972; 27(2):198-210. PubMed ID: 4633329
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug resistance in Mycobacteria tuberculosis in the Barents region of Russia and Norway].
    Mar'iandyshev AO; Tungusova OS; Kaugan D; Sandven P
    Probl Tuberk; 2002; (2):41-3. PubMed ID: 11899806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Importance of the urban and rural environment in prognosis of cavitary pulmonary tuberculosis in the era of tuberculostatics].
    Barbu E; Nistea I; Moga R
    Ftiziologia; 1972; 21(6):571-82. PubMed ID: 4644834
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antimicrobial resistance in tuberculosis].
    Gutiérrez-Aroca JB; Ruiz P; Casal M
    Rev Esp Quimioter; 2013 Dec; 26(4):332-6. PubMed ID: 24399346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
    Il'iuna TIa; Zhangireev AA; Sidorenko OA
    Probl Tuberk Bolezn Legk; 2008; (5):20-2. PubMed ID: 18711814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of aggravating factors on the effectiveness of the treatment of newly detected patients with destructive pulmonary tuberculosis].
    Zozuliak VI
    Vrach Delo; 1988 Jun; (6):54-5. PubMed ID: 3138824
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug resistance of Mycobacterium tuberculosis in patients with pulmonary tuberculosis treated in the santorium in Abastumani].
    Shilakadze EM; Margadze GKh; Zautashvili MG
    Probl Tuberk; 1975; (3):79. PubMed ID: 124432
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current bacteriologic and clinical aspects of chemo-antibiotic therapy of pulmonary tuberculosis].
    Saltini C; Velluti G; Mantovani P
    Arch Monaldi; 1978; 33(4):251-79. PubMed ID: 116622
    [No Abstract]   [Full Text] [Related]  

  • 40. [Incidence of primary resistance to antitubercular agents in the Toulouse area].
    Puel J; Galtier M; Lareng MB; Delaude A
    Arch Monaldi; 1972; 27(4):418-25. PubMed ID: 4217598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.